Pavlos Texakalidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pavlos Texakalidis has a total of 181 co-authors. Here are the top co-authors by number of shared publications:
- Stefanos Giannopoulos
Stony Brook University Hospital
16 shared publications John Reavey-Cantwell
Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA
11 shared publicationsLeonardo Rangel-Castilla
Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA
11 shared publicationsPascal Jabbour
Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
9 shared publications- Muhibullah Sayed Tora
Department of Neurosurgery, School of Medicine, Emory University Hospital, 101 Woodruff Circle, Suite 6204, Atlanta, GA, 30322, USA.
8 shared publications - Nicholas M. Boulis
Department of Neurosurgery, Emory University School of Medicine, Atlanta, USA
8 shared publications
Latest Publications
- Open Access
Percutaneous peripheral nerve stimulation as an ancillary treatment following nerve repair surgery
Background: Neuropathic pain after peripheral nerve injury severely degrades quality of life. Peripheral nerve stimulation (PN‐Stim) is cleared by the U.S, Food and Drug Administration for the treatment of acute and chronic pain. This broad indication supports its potential use at the time of peripheral nerve repair in patients reporting neuropathic pain preoperatively. Objective: To explore the safety and therapeutic effects of PN‐Stim on neuropathic pain in patients with severe peripheral nerve injuries undergoing surgical nerve repair. Methods: We analyzed 16 consecutive patients 18 years and older who received PN‐Stim implantation at the time of nerve repair surgery. Patients younger than 18 years of age, pregnant, and those without preoperative pain associated with nerve injury were excluded from our study. The primary outcome was pain score reduction, which was evaluated by Visual Analog Scale. The secondary outcomes included motor functional recovery and opioid usage, which were evaluated by manual muscle testing (MMT) and Morphine Milligram Equivalents quantification, respectively. Statistical analyses used paired two‐tailed t ‐tests and Wilcoxon sign tests, contingent on data normalcy. Results: Pain scores decreased significantly post‐PN‐Stim implantation (mean preplacement: 7.35, postplacement: 2.56; p < .05). MMT scores showed improvement in 13 patients, with 2 achieving the maximum MMT score ( p < .05). Chronic opioid usage was observed to decrease in six of seven patients who were using them ( p < .05). No significant adverse effects were seen after implantation. Conclusion: In this case series of 16 patients with various peripheral nerve injuries who each underwent peripheral nerve repair surgery and concomitant placement of a temporary peripheral nerve stimulator, there were no adverse effects attributable to the peripheral nerve stimulator.
Open AccessPercutaneous peripheral nerve stimulation as an ancillary treatment following nerve repair surgery
Background: Neuropathic pain after peripheral nerve injury severely degrades quality of life. Peripheral nerve stimulation (PN‐Stim) is cleared by the U.S, Food and Drug Administration for the treatment of acute and chronic pain. This broad indication supports its potential use at the time of peripheral nerve repair in patients reporting neuropathic pain preoperatively. Objective: To explore the safety and therapeutic effects of PN‐Stim on neuropathic pain in patients with severe peripheral nerve injuries undergoing surgical nerve repair. Methods: We analyzed 16 consecutive patients 18 years and older who received PN‐Stim implantation at the time of nerve repair surgery. Patients younger than 18 years of age, pregnant, and those without preoperative pain associated with nerve injury were excluded from our study. The primary outcome was pain score reduction, which was evaluated by Visual Analog Scale. The secondary outcomes included motor functional recovery and opioid usage, which were evaluated by manual muscle testing (MMT) and Morphine Milligram Equivalents quantification, respectively. Statistical analyses used paired two‐tailed t ‐tests and Wilcoxon sign tests, contingent on data normalcy. Results: Pain scores decreased significantly post‐PN‐Stim implantation (mean preplacement: 7.35, postplacement: 2.56; p < .05). MMT scores showed improvement in 13 patients, with 2 achieving the maximum MMT score ( p < .05). Chronic opioid usage was observed to decrease in six of seven patients who were using them ( p < .05). No significant adverse effects were seen after implantation. Conclusion: In this case series of 16 patients with various peripheral nerve injuries who each underwent peripheral nerve repair surgery and concomitant placement of a temporary peripheral nerve stimulator, there were no adverse effects attributable to the peripheral nerve stimulator.
- Open Access
- 4 May 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (18)
Differential awakening of the sciatic nerve: illustrative case
BACKGROUND: Differential awakening is a well-known, yet poorly understood phenomenon seen in patients with intracranial pathologies. Because acute postoperative neurological decline has many potentially reversible causes, distinguishing differential awakening from other etiologies is critical. To the authors’ knowledge, differential awakening has not been reported following peripheral nerve procedures. OBSERVATIONS: A 40-year-old man presented with a 1.5-year history of painful bilateral cervical and right lumbosacral radiculoplexus neuropathy recently associated with bilateral facial and vestibulocochlear neuropathy. He had not responded to treatment trials. A sciatic nerve lesion in the sciatic notch was identified on imaging and an open biopsy of the posterior femoral cutaneous nerve was pursued. Immediately after emergence from anesthesia, he demonstrated a complete inability to dorsiflex or plantar flex the right foot, despite minimal intraoperative manipulation of the sciatic nerve. Over the ensuing hour, motor function progressively returned to baseline. The transient postoperative motor deficit was attributed to differential awakening of the sciatic nerve. Pathological analysis confirmed high-grade B-cell lymphoma. LESSONS: Differential awakening may be an underrecognized cause of transient neurological worsening during emergence from anesthesia following peripheral nerve surgery. Further investigation is needed to clarify the underlying mechanisms and define its incidence and risk factors. https://thejns.org/doi/10.3171/CASE251028
- 4 May 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (18)
Open AccessDifferential awakening of the sciatic nerve: illustrative case
BACKGROUND: Differential awakening is a well-known, yet poorly understood phenomenon seen in patients with intracranial pathologies. Because acute postoperative neurological decline has many potentially reversible causes, distinguishing differential awakening from other etiologies is critical. To the authors’ knowledge, differential awakening has not been reported following peripheral nerve procedures. OBSERVATIONS: A 40-year-old man presented with a 1.5-year history of painful bilateral cervical and right lumbosacral radiculoplexus neuropathy recently associated with bilateral facial and vestibulocochlear neuropathy. He had not responded to treatment trials. A sciatic nerve lesion in the sciatic notch was identified on imaging and an open biopsy of the posterior femoral cutaneous nerve was pursued. Immediately after emergence from anesthesia, he demonstrated a complete inability to dorsiflex or plantar flex the right foot, despite minimal intraoperative manipulation of the sciatic nerve. Over the ensuing hour, motor function progressively returned to baseline. The transient postoperative motor deficit was attributed to differential awakening of the sciatic nerve. Pathological analysis confirmed high-grade B-cell lymphoma. LESSONS: Differential awakening may be an underrecognized cause of transient neurological worsening during emergence from anesthesia following peripheral nerve surgery. Further investigation is needed to clarify the underlying mechanisms and define its incidence and risk factors. https://thejns.org/doi/10.3171/CASE251028
- 23 April 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Tibial and Plantar Intraneural Ganglion Cysts in the Ankle Region: Analysis Supports Articular Origin to Subtalar and Tibiotalar Joints and Differing Patterns of Propagation
BACKGROUND AND OBJECTIVES: Intraneural ganglion cysts (IGCs) can arise in different nerves but are uncommon in the tibial nerve (TN) and its branches near the ankle. According to the unified articular theory, a joint connection is always present in IGCs. This study aimed to identify joint connections of tibial-region IGCs and characterize their clinical, radiological, and propagation patterns. METHODS: A prospectively collected international database of >1100 IGCs was reviewed to identify tibial and medial plantar nerve (MPN) and lateral plantar nerve (LPN) IGCs around the ankle. RESULTS: Sixty-two ankle region IGCs were identified: 29 involving the TN (46.8%), 25 the MPN (40.3%), and 4 the LPN (6.4%); in 4 cases, the parent nerve was indeterminate. Thirty-one (50%) cases demonstrated joint connections. Of these, all TN at/distal to the tarsal tunnel (n = 4/4, 100%), MPN (n = 16/16, 100%) and LPN IGCs (n = 2/2, 100%) had a connection to the subtalar (ST) joint. A tibial IGC just proximal to the tarsal tunnel was connected to the tibiotalar (TT) joint in 75% of cases (n = 3/4) and the ST joint in 25% of cases (n = 1/4). Surgical ligation/disconnection of the articular branch was associated with markedly lower recurrence (0/13, 0%) compared with incision or resection of cyst without ligation (8/29, 27.6%; P = .04). CONCLUSION: Our findings support the unified articular theory. All IGCs in the ankle primarily ascend. Two distinct propagation patterns emerged: (1) those that ascend and enter the parent nerve proximal to the tarsal tunnel continue to ascend in the leg, without affecting the plantar nerves, and (2) those that ascend and enter the parent nerve at/distal to the tarsal tunnel have the potential to undergo crossover at the TN bifurcation and subsequently descend down the plantar nerves seen only in ST-origin cysts. Recognizing these pathways enhances diagnostic accuracy, directs identification of the joint of origin, and guides articular branch disconnection to reduce recurrence.
- 23 April 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Tibial and Plantar Intraneural Ganglion Cysts in the Ankle Region: Analysis Supports Articular Origin to Subtalar and Tibiotalar Joints and Differing Patterns of Propagation
BACKGROUND AND OBJECTIVES: Intraneural ganglion cysts (IGCs) can arise in different nerves but are uncommon in the tibial nerve (TN) and its branches near the ankle. According to the unified articular theory, a joint connection is always present in IGCs. This study aimed to identify joint connections of tibial-region IGCs and characterize their clinical, radiological, and propagation patterns. METHODS: A prospectively collected international database of >1100 IGCs was reviewed to identify tibial and medial plantar nerve (MPN) and lateral plantar nerve (LPN) IGCs around the ankle. RESULTS: Sixty-two ankle region IGCs were identified: 29 involving the TN (46.8%), 25 the MPN (40.3%), and 4 the LPN (6.4%); in 4 cases, the parent nerve was indeterminate. Thirty-one (50%) cases demonstrated joint connections. Of these, all TN at/distal to the tarsal tunnel (n = 4/4, 100%), MPN (n = 16/16, 100%) and LPN IGCs (n = 2/2, 100%) had a connection to the subtalar (ST) joint. A tibial IGC just proximal to the tarsal tunnel was connected to the tibiotalar (TT) joint in 75% of cases (n = 3/4) and the ST joint in 25% of cases (n = 1/4). Surgical ligation/disconnection of the articular branch was associated with markedly lower recurrence (0/13, 0%) compared with incision or resection of cyst without ligation (8/29, 27.6%; P = .04). CONCLUSION: Our findings support the unified articular theory. All IGCs in the ankle primarily ascend. Two distinct propagation patterns emerged: (1) those that ascend and enter the parent nerve proximal to the tarsal tunnel continue to ascend in the leg, without affecting the plantar nerves, and (2) those that ascend and enter the parent nerve at/distal to the tarsal tunnel have the potential to undergo crossover at the TN bifurcation and subsequently descend down the plantar nerves seen only in ST-origin cysts. Recognizing these pathways enhances diagnostic accuracy, directs identification of the joint of origin, and guides articular branch disconnection to reduce recurrence.
- Open Access
- 23 March 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (12)
Perineural spread of colorectal carcinoma into the sciatic nerve with positive circulating tumor DNA test: illustrative case
BACKGROUND: Perineural spread (PNS) of colorectal carcinoma (CRC) is a rare and challenging diagnosis. Its clinical and radiological presentation is often subtle and can overlap with radiation-induced neuropathy and malignant nerve tumors, complicating timely diagnosis. The role of circulating tumor DNA (ctDNA) in the detection of PNS has not been previously described. OBSERVATIONS: A 48-year-old man with a history of rectal cancer and perineural invasion presented with progressive, refractory sciatic neuropathic pain. Conventional surveillance imaging was initially negative despite subtle rising of carcinoembryonic antigen and ctDNA levels. Subsequent MRI revealed abnormalities of the lumbosacral plexus and sciatic nerve, and fascicular biopsy confirmed metastatic CRC involving the sciatic nerve, establishing the diagnosis of PNS. LESSONS: This case highlights PNS as a rare but important consideration in patients with focal neuropathic symptoms and prior CRC. Circulating tumor DNA positivity may serve as an early indicator of occult tumor activity even within the nerves when imaging is equivocal. However, currently histopathological confirmation remains the only definitive method to distinguish PNS from alternative diagnoses and is essential to guide appropriate management. https://thejns.org/doi/10.3171/CASE25997
- 23 March 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (12)
Open AccessPerineural spread of colorectal carcinoma into the sciatic nerve with positive circulating tumor DNA test: illustrative case
BACKGROUND: Perineural spread (PNS) of colorectal carcinoma (CRC) is a rare and challenging diagnosis. Its clinical and radiological presentation is often subtle and can overlap with radiation-induced neuropathy and malignant nerve tumors, complicating timely diagnosis. The role of circulating tumor DNA (ctDNA) in the detection of PNS has not been previously described. OBSERVATIONS: A 48-year-old man with a history of rectal cancer and perineural invasion presented with progressive, refractory sciatic neuropathic pain. Conventional surveillance imaging was initially negative despite subtle rising of carcinoembryonic antigen and ctDNA levels. Subsequent MRI revealed abnormalities of the lumbosacral plexus and sciatic nerve, and fascicular biopsy confirmed metastatic CRC involving the sciatic nerve, establishing the diagnosis of PNS. LESSONS: This case highlights PNS as a rare but important consideration in patients with focal neuropathic symptoms and prior CRC. Circulating tumor DNA positivity may serve as an early indicator of occult tumor activity even within the nerves when imaging is equivocal. However, currently histopathological confirmation remains the only definitive method to distinguish PNS from alternative diagnoses and is essential to guide appropriate management. https://thejns.org/doi/10.3171/CASE25997
- Open Access
- 23 March 2026
- Vol. 11 (12)
Perineural spread of colorectal carcinoma into the sciatic nerve with positive circulating tumor DNA test: illustrative case
Perineural spread (PNS) of colorectal carcinoma (CRC) is a rare and challenging diagnosis. Its clinical and radiological presentation is often subtle and can overlap with radiation-induced neuropathy and malignant nerve tumors, complicating timely diagnosis. The role of circulating tumor DNA (ctDNA) in the detection of PNS has not been previously described. A 48-year-old man with a history of rectal cancer and perineural invasion presented with progressive, refractory sciatic neuropathic pain. Conventional surveillance imaging was initially negative despite subtle rising of carcinoembryonic antigen and ctDNA levels. Subsequent MRI revealed abnormalities of the lumbosacral plexus and sciatic nerve, and fascicular biopsy confirmed metastatic CRC involving the sciatic nerve, establishing the diagnosis of PNS. This case highlights PNS as a rare but important consideration in patients with focal neuropathic symptoms and prior CRC. Circulating tumor DNA positivity may serve as an early indicator of occult tumor activity even within the nerves when imaging is equivocal. However, currently histopathological confirmation remains the only definitive method to distinguish PNS from alternative diagnoses and is essential to guide appropriate management. https://thejns.org/doi/10.3171/CASE25997
- 23 March 2026
- Vol. 11 (12)
Open AccessPerineural spread of colorectal carcinoma into the sciatic nerve with positive circulating tumor DNA test: illustrative case
Perineural spread (PNS) of colorectal carcinoma (CRC) is a rare and challenging diagnosis. Its clinical and radiological presentation is often subtle and can overlap with radiation-induced neuropathy and malignant nerve tumors, complicating timely diagnosis. The role of circulating tumor DNA (ctDNA) in the detection of PNS has not been previously described. A 48-year-old man with a history of rectal cancer and perineural invasion presented with progressive, refractory sciatic neuropathic pain. Conventional surveillance imaging was initially negative despite subtle rising of carcinoembryonic antigen and ctDNA levels. Subsequent MRI revealed abnormalities of the lumbosacral plexus and sciatic nerve, and fascicular biopsy confirmed metastatic CRC involving the sciatic nerve, establishing the diagnosis of PNS. This case highlights PNS as a rare but important consideration in patients with focal neuropathic symptoms and prior CRC. Circulating tumor DNA positivity may serve as an early indicator of occult tumor activity even within the nerves when imaging is equivocal. However, currently histopathological confirmation remains the only definitive method to distinguish PNS from alternative diagnoses and is essential to guide appropriate management. https://thejns.org/doi/10.3171/CASE25997
- Open Access
- 18 March 2026
- Published by Wolters Kluwer Health in Journal of Craniovertebral Junction and Spine
- Vol. 17 (2) , 108-117
Outcomes of lumbar fusion surgery in isthmic versus degenerative spondylolisthesis: A systematic review and meta-analysis
Lumbar spondylolisthesis can cause a significant disability due to back and lower extremity pain. Degenerative spondylolisthesis (DS) and isthmic spondylolisthesis (IS) are the two most common types. DS results from arthritic changes and degenerative disc disease, whereas IS occurs secondary to a pars interarticularis defect. This study compared surgical outcomes between IS and DS. A systematic literature review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Twenty studies comprising 3136 patients were included (DS: 1944; IS: 1192). No differences were identified in terms of estimated blood loss (mean difference [MD]: 5.79, 95% confidence interval [CI]: 42.88, 54.46; I 2 = 81.7%), length of stay (MD: 0.24, 95% CI: 1.38–0.90; I 2 = 87.7%), duration of operation (MD: 2.73, 95% CI: 20.61–15.16; I 2 = 84.7%), reduction of Visual Analog Scale (VAS) for back pain before and after surgery (MD: 0.01, 95% CI: 0.68–0.65; I 2 = 87.5%), reduction in Oswestry Disability Index before and after surgery (MD: 1.37, 95% CI: 2.39–5.12; I 2 = 75.5%), return to operating room for any reason (odds ratio [OR]: 1.01, 95% CI: 0.48–2.15; I 2 = 0%), successful fusion at the last follow-up (OR: 0.68, 95% CI: 0.26–1.77; I 2 = 60.5%), adjacent segment disease during follow-up (OR: 0.45, 95% CI: 0.18–1.13; I 2 = 0%), and subjective unsatisfactory outcome (OR: 1.53; 95% CI: 0.99–2.35; I 2 = 0%). IS was associated with significantly higher odds for reporting subjective unsatisfactory outcome compared to DS (OR: 1.56; 95% CI: 1.00–2.43, I 2 : 0%) in the subgroup analysis of posterior lumbar interbody fusion/transforaminal lumbar interbody fusion. DS showed greater VAS back pain reduction than IS with posterolateral fusion alone (MD: -1.06, 95% CI: -1.90–0.22, I 2 :0%). Surgical outcomes are largely comparable between IS and DS, though etiology-specific differences in patient-reported outcomes may depend on fusion technique.
- 18 March 2026
- Published by Wolters Kluwer Health in Journal of Craniovertebral Junction and Spine
- Vol. 17 (2) , 108-117
Open AccessOutcomes of lumbar fusion surgery in isthmic versus degenerative spondylolisthesis: A systematic review and meta-analysis
Lumbar spondylolisthesis can cause a significant disability due to back and lower extremity pain. Degenerative spondylolisthesis (DS) and isthmic spondylolisthesis (IS) are the two most common types. DS results from arthritic changes and degenerative disc disease, whereas IS occurs secondary to a pars interarticularis defect. This study compared surgical outcomes between IS and DS. A systematic literature review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Twenty studies comprising 3136 patients were included (DS: 1944; IS: 1192). No differences were identified in terms of estimated blood loss (mean difference [MD]: 5.79, 95% confidence interval [CI]: 42.88, 54.46; I 2 = 81.7%), length of stay (MD: 0.24, 95% CI: 1.38–0.90; I 2 = 87.7%), duration of operation (MD: 2.73, 95% CI: 20.61–15.16; I 2 = 84.7%), reduction of Visual Analog Scale (VAS) for back pain before and after surgery (MD: 0.01, 95% CI: 0.68–0.65; I 2 = 87.5%), reduction in Oswestry Disability Index before and after surgery (MD: 1.37, 95% CI: 2.39–5.12; I 2 = 75.5%), return to operating room for any reason (odds ratio [OR]: 1.01, 95% CI: 0.48–2.15; I 2 = 0%), successful fusion at the last follow-up (OR: 0.68, 95% CI: 0.26–1.77; I 2 = 60.5%), adjacent segment disease during follow-up (OR: 0.45, 95% CI: 0.18–1.13; I 2 = 0%), and subjective unsatisfactory outcome (OR: 1.53; 95% CI: 0.99–2.35; I 2 = 0%). IS was associated with significantly higher odds for reporting subjective unsatisfactory outcome compared to DS (OR: 1.56; 95% CI: 1.00–2.43, I 2 : 0%) in the subgroup analysis of posterior lumbar interbody fusion/transforaminal lumbar interbody fusion. DS showed greater VAS back pain reduction than IS with posterolateral fusion alone (MD: -1.06, 95% CI: -1.90–0.22, I 2 :0%). Surgical outcomes are largely comparable between IS and DS, though etiology-specific differences in patient-reported outcomes may depend on fusion technique.
- 12 February 2026
- Published by Elsevier in World Neurosurgery
- Vol. 207, 124796
Whose Hands on the Robot? Rethinking Roles in Nerve Sheath Tumor Surgery
- 12 February 2026
- Published by Elsevier in World Neurosurgery
- Vol. 207, 124796
Whose Hands on the Robot? Rethinking Roles in Nerve Sheath Tumor Surgery
- Open Access
- 29 December 2025
- Published by Elsevier in World Neurosurgery
- Vol. 206, 124765
What's New with Intraneural Ganglion Cysts?
- 29 December 2025
- Published by Elsevier in World Neurosurgery
- Vol. 206, 124765
Open AccessWhat's New with Intraneural Ganglion Cysts?
- Open Access
- 24 November 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (1) , 218-222
Intrathecal Administration of Riluzole in Amyotrophic Lateral Sclerosis
BACKGROUND AND OBJECTIVES: Riluzole is the only treatment known to improve survival in amyotrophic lateral sclerosis (ALS) patients. However, its efficacy and dosing are limited by hepatic toxicity and interindividual pharmacokinetic variability. Recent experimental studies in hounds have shown that continuous intrathecal (IT) administration of riluzole is well tolerated and achieves significantly higher spinal cord tissue levels. We report the first 2 human ALS cases treated with IT riluzole. METHODS: A catheter was inserted into the lumbar cistern and advanced to the midcervical region under fluoroscopic guidance and connected to a subcutaneous pump. Therapy was initiated at 0.1 mg/h of riluzole. The infusion rate was gradually increased until it reached a maximum of 4.8 mg/d. RESULTS: The 2 patients tolerated dose escalation and treatment for over 2 years without apparent motor or sensory complications. Patients reported no asthenia, a central side effect often reported as a reason to abandon oral therapy. CONCLUSION: This is the first report of chronic IT riluzole infusion in humans at a dose found to be safe in canines. A phase 1 study is planned to establish the maximum tolerated human dose, followed by a randomized placebo-controlled trial to determine the safety and tolerability of IT riluzole in patients with ALS.
- 24 November 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (1) , 218-222
Open AccessIntrathecal Administration of Riluzole in Amyotrophic Lateral Sclerosis
BACKGROUND AND OBJECTIVES: Riluzole is the only treatment known to improve survival in amyotrophic lateral sclerosis (ALS) patients. However, its efficacy and dosing are limited by hepatic toxicity and interindividual pharmacokinetic variability. Recent experimental studies in hounds have shown that continuous intrathecal (IT) administration of riluzole is well tolerated and achieves significantly higher spinal cord tissue levels. We report the first 2 human ALS cases treated with IT riluzole. METHODS: A catheter was inserted into the lumbar cistern and advanced to the midcervical region under fluoroscopic guidance and connected to a subcutaneous pump. Therapy was initiated at 0.1 mg/h of riluzole. The infusion rate was gradually increased until it reached a maximum of 4.8 mg/d. RESULTS: The 2 patients tolerated dose escalation and treatment for over 2 years without apparent motor or sensory complications. Patients reported no asthenia, a central side effect often reported as a reason to abandon oral therapy. CONCLUSION: This is the first report of chronic IT riluzole infusion in humans at a dose found to be safe in canines. A phase 1 study is planned to establish the maximum tolerated human dose, followed by a randomized placebo-controlled trial to determine the safety and tolerability of IT riluzole in patients with ALS.
- 23 June 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (4) , 506-512
Double Supinator Branch Transfer to Posterior Interosseous Nerve May Confer Superior Hand Opening Restoration Outcomes in Brachial Plexus and Spinal Cord Injury Compared to Single Branch
BACKGROUND AND OBJECTIVES: Cervical spinal cord injury (SCI) and lower trunk brachial plexus injury (BPI) commonly result in hand paralysis. The supinator to posterior interosseous nerve (SPIN) transfer is a well-established surgical approach that can achieve restoration of hand opening with similar outcomes in SCI and BPI. Most often, the radial nerve has 2 branches to the supinator. Studies have reported utilization of either single or double supinator branches as donors for the SPIN transfer. The aim of this study was to study whether using one or both supinator branches can affect recovery of hand opening. METHODS: A systematic literature review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. All studies reporting outcomes of the SPIN transfer were included. RESULTS: A total of 16 studies with 108 patients and 152 SPIN transfers were included (132 with double and 20 with single supinator donor branches; 123 for SCI and 29 for BPI). Four of the 16 included studies reported the use of a single motor supinator branch as a donor, while the remaining 12 studies used both branches. The average time interval from injury to surgery was P = .016), respectively. Thumb extension restoration was achieved in 60% (12/20) and 83.3% (110/132) of the single and double branch transfers ( P = .014), respectively. The median reported follow-up was more than 20 months per study. One patient in the cohort developed supination weakness; however, this patient had preexisting biceps weakness. Four patients developed temporary wrist extension weakness. CONCLUSION: Utilization of both supinator branches for the SPIN transfer might achieve superior hand opening outcomes in SCI and BPI, compared with the single supinator branch.
- 23 June 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 30 (4) , 506-512
Double Supinator Branch Transfer to Posterior Interosseous Nerve May Confer Superior Hand Opening Restoration Outcomes in Brachial Plexus and Spinal Cord Injury Compared to Single Branch
BACKGROUND AND OBJECTIVES: Cervical spinal cord injury (SCI) and lower trunk brachial plexus injury (BPI) commonly result in hand paralysis. The supinator to posterior interosseous nerve (SPIN) transfer is a well-established surgical approach that can achieve restoration of hand opening with similar outcomes in SCI and BPI. Most often, the radial nerve has 2 branches to the supinator. Studies have reported utilization of either single or double supinator branches as donors for the SPIN transfer. The aim of this study was to study whether using one or both supinator branches can affect recovery of hand opening. METHODS: A systematic literature review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. All studies reporting outcomes of the SPIN transfer were included. RESULTS: A total of 16 studies with 108 patients and 152 SPIN transfers were included (132 with double and 20 with single supinator donor branches; 123 for SCI and 29 for BPI). Four of the 16 included studies reported the use of a single motor supinator branch as a donor, while the remaining 12 studies used both branches. The average time interval from injury to surgery was P = .016), respectively. Thumb extension restoration was achieved in 60% (12/20) and 83.3% (110/132) of the single and double branch transfers ( P = .014), respectively. The median reported follow-up was more than 20 months per study. One patient in the cohort developed supination weakness; however, this patient had preexisting biceps weakness. Four patients developed temporary wrist extension weakness. CONCLUSION: Utilization of both supinator branches for the SPIN transfer might achieve superior hand opening outcomes in SCI and BPI, compared with the single supinator branch.